PET ties coronary blood flow to future adverse events
November 20, 2020 -- Using PET perfusion to gauge cardiac blood flow capacity, researchers have found that severely reduced coronary flow reserve is a key contributor to a greater risk of a major adverse cardiac event and death, according to a study published online November 18 in Cardiovascular Imaging.
Discuss
November 20, 2020 -- Using PET perfusion to gauge cardiac blood flow capacity, researchers have found that severely reduced coronary flow reserve is a key contributor to a greater risk of a major adverse cardiac event and death, according to a study published online November 18 in Cardiovascular Imaging.
Discuss Tau Alzheimer's blood test gives PET a run for its money
November 10, 2020 -- Blood tests that detect a biomarker for abnormal tau metabolism in the brain were able to detect pathology earlier than PET scans in patients with preclinical Alzheimer's disease in a study reported online November 9 in JAMA Neurology.
Discuss
November 10, 2020 -- Blood tests that detect a biomarker for abnormal tau metabolism in the brain were able to detect pathology earlier than PET scans in patients with preclinical Alzheimer's disease in a study reported online November 9 in JAMA Neurology.
Discuss Coding and documentation for Y-90 radioembolization
November 9, 2020 -- The treatment of liver tumors using yttrium-90 (Y-90) radioembolization brings unusual challenges for interventional radiologists. Erin Stephens of Healthcare Administrative Partners describes how to overcome them.
Discuss
November 9, 2020 -- The treatment of liver tumors using yttrium-90 (Y-90) radioembolization brings unusual challenges for interventional radiologists. Erin Stephens of Healthcare Administrative Partners describes how to overcome them.
Discuss PET/CT with Ga-68 tracer better for cancer patients
November 2, 2020 -- By attaching gallium-68 (Ga-68) to a fibroblast activation protein molecule inhibitor, German researchers have achieved greater accuracy with PET/CT in staging patients with pancreatic ductal adenocarcinoma, according to a study published online October 23 in the Journal of Nuclear Medicine.
Discuss
November 2, 2020 -- By attaching gallium-68 (Ga-68) to a fibroblast activation protein molecule inhibitor, German researchers have achieved greater accuracy with PET/CT in staging patients with pancreatic ductal adenocarcinoma, according to a study published online October 23 in the Journal of Nuclear Medicine.
Discuss Emerging PET tracer excels at tau pathology, differentiates dementias
October 29, 2020 -- A new PET radiotracer for tau pathologies is showing promise for helping diagnose and differentiate Alzheimer's disease from a wide range of other dementia disorders. Researchers detailed their early experiences in animal and patient studies in Neuron online October 29.
Discuss
October 29, 2020 -- A new PET radiotracer for tau pathologies is showing promise for helping diagnose and differentiate Alzheimer's disease from a wide range of other dementia disorders. Researchers detailed their early experiences in animal and patient studies in Neuron online October 29.
Discuss Use F-18 fluciclovine PET/MRI to stage prostate cancer
October 28, 2020 -- PET/MRI with the F-18 fluciclovine radiotracer shows promise for initial staging of high-risk prostate cancer and for evaluating response to androgen deprivation therapy, according to a pilot study published online October 14 in the American Journal of Roentgenology.
Discuss
October 28, 2020 -- PET/MRI with the F-18 fluciclovine radiotracer shows promise for initial staging of high-risk prostate cancer and for evaluating response to androgen deprivation therapy, according to a pilot study published online October 14 in the American Journal of Roentgenology.
Discuss PSMA-PET reveals new salivary glands
October 28, 2020 -- Imaging with the use of prostate-specific membrane antigen (PSMA) has led to the discovery of a pair of salivary glands, found tucked away inside the skull where the nasal cavity and throat meet. The findings were published recently in Radiotherapy & Oncology.
Discuss
October 28, 2020 -- Imaging with the use of prostate-specific membrane antigen (PSMA) has led to the discovery of a pair of salivary glands, found tucked away inside the skull where the nasal cavity and throat meet. The findings were published recently in Radiotherapy & Oncology.
Discuss PET with Axumin boosts prostate cancer outcomes
October 27, 2020 -- Patients with recurrent prostate cancer had better outcomes when PET with the Axumin radiopharmaceutical was part of the imaging package guiding their radiation therapy, according to a study presented on October 26 at the American Society for Radiation Oncology annual meeting.
Discuss
October 27, 2020 -- Patients with recurrent prostate cancer had better outcomes when PET with the Axumin radiopharmaceutical was part of the imaging package guiding their radiation therapy, according to a study presented on October 26 at the American Society for Radiation Oncology annual meeting.
Discuss Radiomics can aid management of lung cancer patients
October 26, 2020 -- Researchers from the H. Lee Moffitt Cancer Center and Research Institute in Tampa, FL, have reported that CT radiomics features can help predict tumor behavior in screening-detected lung cancer. They've also found that PET/CT radiomics shows promise for guiding non-small cell lung cancer treatment decisions.
Discuss
October 26, 2020 -- Researchers from the H. Lee Moffitt Cancer Center and Research Institute in Tampa, FL, have reported that CT radiomics features can help predict tumor behavior in screening-detected lung cancer. They've also found that PET/CT radiomics shows promise for guiding non-small cell lung cancer treatment decisions.
Discuss AI aids detection of metastasis on bone scintigraphy
October 13, 2020 -- An artificial intelligence (AI) model was able to help nuclear medicine physicians improve their performance in diagnosing bone metastases on bone scintigraphy exams in patients with breast, lung, prostate, or other cancers, according to research published online October 12 in Scientific Reports.
Discuss
October 13, 2020 -- An artificial intelligence (AI) model was able to help nuclear medicine physicians improve their performance in diagnosing bone metastases on bone scintigraphy exams in patients with breast, lung, prostate, or other cancers, according to research published online October 12 in Scientific Reports.
Discuss
Special Feature
Nuclear medicine guidelines promote COVID-19 safety
How can nuclear medicine departments keep patients and staff safe during the COVID-19 pandemic? A new set of guidelines from the IAEA provides some guidance.. Read more
Industry News
VENDOR CONNECT
Conferences
Imaging in the Bahamas
January 18-21, 2021
Nassau, New Providence Bahamas
January 18-21, 2021
Nassau, New Providence Bahamas
23rd UC San Diego Advanced Imaging at Alta
February 21-26, 2021
Alta, Utah United States
February 21-26, 2021
Alta, Utah United States
Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2021 Annual Meeting
June 12-15, 2021
Washington, DC, District of Columbia United States
June 12-15, 2021
Washington, DC, District of Columbia United States